CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Morgan Stanley Downgrades MapLight Therapeutics to Equalweight From Overweight, $34 PT

Negative
AI Analysis

Summary

Morgan Stanley downgraded MapLight Therapeutics from Overweight to Equalweight with a $34 price target.

Importance:3/10
Sentiment:
-0.60
analyst_downgraderating_changeprice_target
Related Companies

Read the original article

Published by yahoo_finance on July 28, 2026 11:24 AM

Read Original